Clinical Trials Browser

Phase 2 × LCL161 × Plasma cell × Clear all

NCT01955434 2019-09-10

SMAC Mimetic LCL161 Alone or With Cyclophosphamide in Treating Patients With Relapsed or Refractory Multiple Myeloma

Phase 2 Completed

25 enrolled 6 charts

Multiple Myeloma